|
US5863561A
|
|
Immune suppressive product
|
|
US5650175A
|
|
Anti-inflammatory factor, method of isolation, and use
|
|
NZ253866A
|
|
The use of hyperimmune milk to retard or delay physiological aging and increase longevity
|
|
US5367054A
|
|
Large-scale purification of egg immunoglobulin
|
|
US5352462A
|
|
Anti-inflammatory factor, method of isolation, and use
|
|
JPH05176754A
|
|
Method for propagation of cell
|
|
AU7891691A
|
|
Immune suppressive product
|
|
US5215746A
|
|
Anti-cholesterolemic egg, vaccine and method for production, and use
|
|
US5242691A
|
|
Anti-inflammatory factor, method of isolation, and use
|
|
US5288496A
|
|
Growth promoters for animals
|
|
US5130128A
|
|
Use of honey as vaccine
|
|
US5194255A
|
|
Antihypertensive hyperimmune milk, production, composition, and use
|
|
US5106618A
|
|
Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
|
|
US5128127A
|
|
Increased protein production in animals
|
|
CA1339933C
|
|
Use of hyperimmune milk product to treat gastrointestinal disorders
|
|
AU2810189A
|
|
Low residual solvent microspheres and microencapsulation process
|
|
IE883278L
|
|
Microencapsulation process
|
|
US4956349A
|
|
Anti-inflammatory factor, method of isolation, and use
|
|
US5198214A
|
|
Anti-mastitis polyvalent vaccine, method of administration and method for production thereof
|
|
US4879110A
|
|
Antihypertensive hyperimmune milk, production, composition, and use
|
